Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Tarlochan Nijjar"'
Autor:
Lawrence K. Cohen, Wendy Stone, Tarlochan Nijjar, Victoria Carr-Brendel, Carol Jasunas, Robert C. Johnson, Varavani Dwarki, Debra Hodgett, Richard Chin, Gloria H. Frost, James H. Brauker
Publikováno v:
Human Gene Therapy. 9:879-888
Immunoisolation of allogeneic cells within a membrane-bound device is a unique approach for gene therapy. We employed an immunoisolation device that protects allograft, but not xenograft, cells from destruction, to implant a human fibroblast line (MS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0588c4eff7a51ab02a808fcc6e4ec02
https://doi.org/10.1089/hum.1998.9.6-879
https://doi.org/10.1089/hum.1998.9.6-879
Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice
Autor:
Tarlochan Nijjar, Lawrence K. Cohen, Jean Smith, Paula Belloni, Anton Berns, S M Clift, Linda B. Couto, Mireille Rabier, Varavani Dwarki
Continuous delivery of factor VIII (FVIII) protein in hemophiliacs by gene therapy will represent a major clinical advance over the current practice of infrequent administration of purified FVIII. Conceptually, retroviral vectors that can permanently
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2b011716878591abd8cb04dfbf845e4
https://europepmc.org/articles/PMC42629/
https://europepmc.org/articles/PMC42629/
